These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 37769118)
1. Consideration of Nevirapine Analogs To Reduce Metabolically Linked Hepatotoxicity: A Cautionary Tale of the Deuteration Approach. Kandel SE; Gracey EG; Lampe JN Chem Res Toxicol; 2023 Oct; 36(10):1631-1642. PubMed ID: 37769118 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of nevirapine analogs to study the metabolic activation of nevirapine. Tateishi Y; Ohe T; Yasuda D; Takahashi K; Nakamura S; Kazuki Y; Mashino T Drug Metab Pharmacokinet; 2020 Apr; 35(2):238-243. PubMed ID: 32184040 [TBL] [Abstract][Full Text] [Related]
3. Twelfth-Position Deuteration of Nevirapine Reduces 12-Hydroxy-Nevirapine Formation and Nevirapine-Induced Hepatocyte Death. Heck CJS; Seneviratne HK; Bumpus NN J Med Chem; 2020 Jun; 63(12):6561-6574. PubMed ID: 32065749 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and characterization of DNA adducts from the HIV reverse transcriptase inhibitor nevirapine. Antunes AM; Duarte MP; Santos PP; Gamboa da Costa G; Heinze TM; Beland FA; Marques MM Chem Res Toxicol; 2008 Jul; 21(7):1443-56. PubMed ID: 18597499 [TBL] [Abstract][Full Text] [Related]
5. Characterization of the in vitro biotransformation of the HIV-1 reverse transcriptase inhibitor nevirapine by human hepatic cytochromes P-450. Erickson DA; Mather G; Trager WF; Levy RH; Keirns JJ Drug Metab Dispos; 1999 Dec; 27(12):1488-95. PubMed ID: 10570031 [TBL] [Abstract][Full Text] [Related]
6. Amino acid adduct formation by the nevirapine metabolite, 12-hydroxynevirapine--a possible factor in nevirapine toxicity. Antunes AM; Godinho AL; Martins IL; Justino GC; Beland FA; Marques MM Chem Res Toxicol; 2010 May; 23(5):888-99. PubMed ID: 20392079 [TBL] [Abstract][Full Text] [Related]
7. 2'-Deoxythymidine adducts from the anti-HIV drug nevirapine. Antunes AM; Wolf B; Oliveira MC; Beland FA; Marques MM Molecules; 2013 Apr; 18(5):4955-71. PubMed ID: 23624649 [TBL] [Abstract][Full Text] [Related]
8. Protein-mediated antagonism between HIV reverse transcriptase ligands nevirapine and MgATP. Zheng X; Mueller GA; DeRose EF; London RE Biophys J; 2013 Jun; 104(12):2695-705. PubMed ID: 23790378 [TBL] [Abstract][Full Text] [Related]
9. Different Reactive Metabolites of Nevirapine Require Distinct Glutathione S-Transferase Isoforms for Bioinactivation. Dekker SJ; Zhang Y; Vos JC; Vermeulen NP; Commandeur JN Chem Res Toxicol; 2016 Dec; 29(12):2136-2144. PubMed ID: 27989146 [TBL] [Abstract][Full Text] [Related]
10. Bioactivation of nevirapine to a reactive quinone methide: implications for liver injury. Sharma AM; Li Y; Novalen M; Hayes MA; Uetrecht J Chem Res Toxicol; 2012 Aug; 25(8):1708-19. PubMed ID: 22793666 [TBL] [Abstract][Full Text] [Related]
11. A dipyrido [2,3-b:3',2'-f]azepine analog of the HIV-1 reverse transcriptase inhibitor nevirapine. Dyatkin AB; Brickwood JR; Proudfoot JR Bioorg Med Chem Lett; 1998 Aug; 8(16):2169-72. PubMed ID: 9873507 [TBL] [Abstract][Full Text] [Related]
12. Novel theoretically designed HIV-1 non-nucleoside reverse transcriptase inhibitors derived from nevirapine. Liu J; He X; Zhang JZ J Mol Model; 2014 Oct; 20(10):2451. PubMed ID: 25234608 [TBL] [Abstract][Full Text] [Related]
13. Novel deletion of HIV type 1 reverse transcriptase residue 69 conferring selective high-level resistance to nevirapine. Suzuki K; Kaufmann GR; Mukaide M; Cunningham P; Harris C; Leas L; Kondo M; Imai M; Pett SL; Finlayson R; Zaunders J; Kelleher A; Cooper DA AIDS Res Hum Retroviruses; 2001 Sep; 17(13):1293-6. PubMed ID: 11559430 [TBL] [Abstract][Full Text] [Related]
14. The N348I mutation at the connection subdomain of HIV-1 reverse transcriptase decreases binding to nevirapine. Schuckmann MM; Marchand B; Hachiya A; Kodama EN; Kirby KA; Singh K; Sarafianos SG J Biol Chem; 2010 Dec; 285(49):38700-9. PubMed ID: 20876531 [TBL] [Abstract][Full Text] [Related]
15. Singularities of nevirapine metabolism: from sex-dependent differences to idiosyncratic toxicity. Marinho AT; Miranda JP; Caixas U; Charneira C; Gonçalves-Dias C; Marques MM; Monteiro EC; Antunes AMM; Pereira SA Drug Metab Rev; 2019 Feb; 51(1):76-90. PubMed ID: 30712401 [TBL] [Abstract][Full Text] [Related]
16. Covalent Histone Modification by an Electrophilic Derivative of the Anti-HIV Drug Nevirapine. Harjivan SG; Charneira C; Martins IL; Pereira SA; Espadas G; Sabidó E; Beland FA; Marques MM; Antunes AMM Molecules; 2021 Mar; 26(5):. PubMed ID: 33802579 [TBL] [Abstract][Full Text] [Related]
17. Protein adducts as prospective biomarkers of nevirapine toxicity. Antunes AM; Godinho AL; Martins IL; Oliveira MC; Gomes RA; Coelho AV; Beland FA; Marques MM Chem Res Toxicol; 2010 Nov; 23(11):1714-25. PubMed ID: 20809596 [TBL] [Abstract][Full Text] [Related]
18. [Antiretroviral agent nevirapine: its pharmacological action and potential for clinical use]. Takeuchi S; Osugi T Nihon Yakurigaku Zasshi; 1999 Oct; 114(4):205-11. PubMed ID: 10584233 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and oxidation of 2-hydroxynevirapine, a metabolite of the HIV reverse transcriptase inhibitor nevirapine. Antunes AM; Novais DA; da Silva JL; Santos PP; Oliveira MC; Beland FA; Marques MM Org Biomol Chem; 2011 Oct; 9(22):7822-35. PubMed ID: 21969039 [TBL] [Abstract][Full Text] [Related]
20. Compensatory role of double mutation N348I/M184V on nevirapine binding landscape: insight from molecular dynamics simulation. Karubiu W; Bhakat S; Soliman ME Protein J; 2014 Oct; 33(5):432-46. PubMed ID: 25107349 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]